AKT1 and pachyonychia congenita: Others have reported that the PI3K-AKT pathway has pleiotropic effects on survival, proliferation, metabolism, and growth pathways of several malignancies41, and its blockade has long been of interest in managing PC, where a compensatory increase in AKT signaling can occur following AR inhibition42.